INTERNATIONAL PATENT: JANUX THERAPEUTICS, INC. FILES APPLICATION FOR "COMPOSITIONS AND USES OF TUMOR ACTIVATED ANTIBODIES TARGETING EGFR AND EFFECTOR CELL ANTIGENS"

GENEVA, Sept. 3 -- JANUX THERAPEUTICS, INC. (10955 Vista Sorrento Parkway, Suite 200San Diego, California 92130) filed a patent application (PCT/US2025/016583) for "COMPOSITIONS AND USES OF TUMOR ACTIVATED ANTIBODIES TARGETING EGFR AND EFFECTOR CELL ANTIGENS" on Feb 20, 2025. With publication no. WO/2025/179012, the details related to the patent application was published on Aug 28, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CAMPBELL, David (10955 Vista Sorrento Parkway, Suite 200San Diego, California 92130), ROBINSON, Byron (10955 Vista Sorrento Parkway, Suite 200San Diego, California 9...